The competitive landscape for the PD-(L)1xVEGF bispecific drug has intensified as several pharmaceutical companies engage in a heated bidding war for Metsera. This development...
The biotech landscape is evolving, and industry veterans John Maraganore and Clive Meanwell recently shared their insights on the challenges and strategies for launching...